Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Osborn

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
The American Journal of Cardiology|May 30, 2016
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial FibrillationVictoria Jacobs, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|March 10, 2011
A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillationGangadhar Malasana, John D Day, J Peter Weiss, et al.
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Environmental Science & Technology|December 27, 2018
A Critical Review of State-of-the-Art and Emerging Approaches to Identify Fracking-Derived Gases and Associated Contaminants in AquifersJ C McIntosh, M J Hendry, C Ballentine, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
American Heart Journal|June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarinKevin G Graves, Heidi T May, Victoria Jacobs, et al.
Journal of Cardiovascular Electrophysiology|May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation proceduresT Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
Heart Rhythm|August 12, 2014
Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementiaVictoria Jacobs, Scott C Woller, Scott Stevens, et al.
Cardiology|May 27, 2010
Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategiesMegan B Smith, Nedra Christensen, Shiquan Wang, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
The American Journal of Cardiology|May 30, 2016
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial FibrillationVictoria Jacobs, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|March 10, 2011
A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillationGangadhar Malasana, John D Day, J Peter Weiss, et al.
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Environmental Science & Technology|December 27, 2018
A Critical Review of State-of-the-Art and Emerging Approaches to Identify Fracking-Derived Gases and Associated Contaminants in AquifersJ C McIntosh, M J Hendry, C Ballentine, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
American Heart Journal|June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarinKevin G Graves, Heidi T May, Victoria Jacobs, et al.
Journal of Cardiovascular Electrophysiology|May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation proceduresT Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
Heart Rhythm|August 12, 2014
Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementiaVictoria Jacobs, Scott C Woller, Scott Stevens, et al.
Cardiology|May 27, 2010
Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategiesMegan B Smith, Nedra Christensen, Shiquan Wang, et al.
Pageof 9